RCL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.177200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.844200E-01
Normal-vs-Stage2
9.745200E-01
Normal-vs-Stage3
1.030230E-01
Normal-vs-Stage4
3.212800E-01
Stage1-vs-Stage2
3.813200E-01
Stage1-vs-Stage3
1.124150E-01
Stage1-vs-Stage4
1.657790E-02
Stage2-vs-Stage3
8.500000E-02
Stage2-vs-Stage4
3.042000E-01
Stage3-vs-Stage4
2.922700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.399400E-01
Normal-vs-AfricanAmerican
8.542400E-01
Normal-vs-Asian
2.567000E-01
Caucasian-vs-AfricanAmerican
6.311000E-01
Caucasian-vs-Asian
7.658100E-02
AfricanAmerican-vs-Asian
1.461190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.599000E-01
Normal-vs-Female
9.410600E-01
Male-vs-Female
1.819800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.979800E-01
Normal-vs-Age(41-60Yrs)
9.741800E-01
Normal-vs-Age(61-80Yrs)
9.045000E-01
Normal-vs-Age(81-100Yrs)
5.703800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.596200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.399600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.293400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.819600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.534200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.335600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.916600E-01
Normal-vs-Daily Drinker
7.578800E-01
Normal-vs-Weekly Drinker
8.330600E-01
Normal-vs-Occasional Drinker
8.238000E-01
Normal-vs-Social Drinker
9.393200E-01
Non Drinker-vs-Daily Drinker
1.991400E-01
Non Drinker-vs-Weekly Drinker
1.461950E-01
Non Drinker-vs-Occasional Drinker
3.110200E-01
Non Drinker-vs-Social Drinker
3.285200E-01
Daily Drinker-vs-Weekly Drinker
4.317200E-01
Daily Drinker-vs-Occasional Drinker
9.872600E-01
Daily Drinker-vs-Social Drinker
8.269600E-01
Weekly Drinker-vs-Occasional Drinker
4.539200E-01
Weekly Drinker-vs-Social Drinker
6.301000E-01
Occasional Drinker-vs-Social Drinker
8.350000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.613600E-01
Normal-vs-Grade 2
7.872000E-01
Normal-vs-Grade 3
7.816600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.377600E-01
Grade 1-vs-Grade 3
6.069600E-01
Grade 1-vs-Grade 4
4.613600E-01
Grade 2-vs-Grade 3
9.097400E-01
Grade 2-vs-Grade 4
7.872000E-01
Grade 3-vs-Grade 4
7.816600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.956400E-01
Normal-vs-NonDiabetic
7.117600E-01
Diabetic-vs-NonDiabetic
4.900200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.333400E-01
Normal-vs-NoPancreatitis
8.169600E-01
Pancreatitis-vs-NoPancreatitis
9.604000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.405200E-01
Normal-vs-N1
9.728400E-01
N0-vs-N1
5.421200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.489800E-01
Normal-vs-TP53-NonMutant
9.171000E-01
TP53-Mutant-vs-TP53-NonMutant
3.398800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
